• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Enantiopure 2,6-disubstituted piperidines bearing one alkene- or alkyne-containing substituent: preparation and application to total syntheses of indolizidine-alkaloids?
  Hui Liu,Deyong Su,Guolin Cheng,Jimin Xu,Xinyan Wang,Yuefei Hu Org. Biomol. Chem., 2010,8, 1899-1904
• 5. Enantiomerically pure 1,3,2-dioxaborolanes: new reagents for the hydroboration of alkynes
  Chem. Commun., 1998, 2651-2652

4-Bromo-3-iodo-6-methoxy-1H-indazole (CAS No. 887569-04-2): A Comprehensive Guide to Its Properties and Applications

4-Bromo-3-iodo-6-methoxy-1H-indazole (CAS No. 887569-04-2) is a highly specialized heterocyclic compound that has garnered significant attention in pharmaceutical and agrochemical research. This bromo-iodo substituted indazole derivative exhibits unique chemical properties, making it a valuable intermediate in organic synthesis and drug discovery. With the increasing demand for halogenated indazole compounds in medicinal chemistry, this particular molecule stands out due to its versatile reactivity pattern and potential biological activities.

The molecular structure of 4-Bromo-3-iodo-6-methoxy-1H-indazole features three distinct functional groups: a bromo substituent at position 4, an iodo group at position 3, and a methoxy moiety at position 6. This strategic arrangement of halogens and alkoxy groups creates multiple reactive sites that are particularly valuable for cross-coupling reactions in modern synthetic chemistry. Researchers have shown growing interest in such polyhalogenated indazole derivatives due to their potential as building blocks for kinase inhibitors and other biologically active molecules.

Recent studies highlight the importance of 4-Bromo-3-iodo-6-methoxy-1H-indazole in the development of novel therapeutic agents. The compound's unique structure makes it particularly suitable for Suzuki-Miyaura coupling and Buchwald-Hartwig amination reactions, which are crucial for creating diverse molecular libraries in drug discovery programs. Pharmaceutical companies are increasingly exploring indazole-based scaffolds for their potential in treating various conditions, driving demand for high-quality intermediates like this compound.

From a synthetic chemistry perspective, the presence of both bromine and iodine atoms in 4-Bromo-3-iodo-6-methoxy-1H-indazole offers distinct advantages. The iodine moiety typically undergoes oxidative addition more readily than bromine, allowing for selective functionalization at different positions. This characteristic makes the compound particularly valuable for sequential cross-coupling strategies and divergent synthesis approaches that are currently trending in medicinal chemistry research.

The methoxy group at position 6 in 4-Bromo-3-iodo-6-methoxy-1H-indazole contributes to the compound's electronic properties and potential hydrogen bonding capabilities. This feature is especially relevant in the context of structure-activity relationship (SAR) studies, where subtle modifications can significantly impact biological activity. Researchers are particularly interested in how such modifications might influence the compound's potential as a protein kinase modulator or other therapeutic target.

Quality control and characterization of 4-Bromo-3-iodo-6-methoxy-1H-indazole typically involve advanced analytical techniques. High-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry are commonly employed to ensure the compound's purity and structural integrity. These quality assurance measures are critical for researchers who require reliable building blocks for their drug discovery projects and medicinal chemistry programs.

The stability and storage conditions of 4-Bromo-3-iodo-6-methoxy-1H-indazole are important considerations for laboratory use. While the compound is generally stable under recommended storage conditions, proper handling in accordance with standard laboratory safety protocols is essential. Researchers should pay particular attention to protecting the compound from light and moisture to maintain its reactivity for subsequent organic transformations and pharmaceutical synthesis applications.

Market trends indicate growing demand for specialized indazole derivatives like 4-Bromo-3-iodo-6-methoxy-1H-indazole. The compound's versatility as a synthetic intermediate has positioned it as a valuable material for contract research organizations (CROs) and pharmaceutical companies engaged in small molecule drug development. Recent patent literature reveals increasing interest in similar structures for various therapeutic applications, suggesting potential growth opportunities for suppliers of high-quality halogenated heterocyclic compounds.

From an environmental and regulatory standpoint, proper disposal methods for 4-Bromo-3-iodo-6-methoxy-1H-indazole and related compounds should follow institutional guidelines for halogenated organic waste. While not classified as highly hazardous, responsible handling and disposal practices are essential components of sustainable chemistry initiatives that are gaining prominence in the pharmaceutical industry and academic research communities.

Future research directions for 4-Bromo-3-iodo-6-methoxy-1H-indazole may explore its potential in emerging areas such as targeted protein degradation and PROTAC technology. The compound's unique structural features could make it suitable for incorporation into bifunctional molecules designed to modulate protein levels within cells. Such applications represent cutting-edge approaches in drug discovery that are currently attracting substantial investment and research attention.

In conclusion, 4-Bromo-3-iodo-6-methoxy-1H-indazole (CAS No. 887569-04-2) represents an important building block in modern medicinal chemistry. Its unique combination of halogen substituents and methoxy functionality offers diverse opportunities for synthetic elaboration, making it valuable for researchers developing novel therapeutic agents. As the demand for specialized heterocyclic compounds continues to grow in pharmaceutical research, compounds like this will likely remain important tools for drug discovery scientists exploring new approaches to address unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)